PKO Investment Management Joint Stock Co purchased a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 3,000 shares of the medical equipment provider's stock, valued at approximately $1,566,000.
Several other institutional investors also recently modified their holdings of ISRG. Norges Bank bought a new position in shares of Intuitive Surgical in the 4th quarter worth about $2,401,493,000. Proficio Capital Partners LLC increased its stake in shares of Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock worth $495,845,000 after acquiring an additional 948,902 shares in the last quarter. Capital Research Global Investors increased its stake in shares of Intuitive Surgical by 25.5% in the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock worth $1,764,904,000 after acquiring an additional 687,906 shares in the last quarter. Raymond James Financial Inc. bought a new position in shares of Intuitive Surgical in the 4th quarter worth about $313,769,000. Finally, Northern Trust Corp increased its stake in shares of Intuitive Surgical by 15.8% in the 4th quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock worth $1,889,126,000 after acquiring an additional 494,496 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In related news, VP Fredrik Widman sold 810 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the transaction, the vice president now owns 473 shares of the company's stock, valued at approximately $271,397.94. This trade represents a 63.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Robert Desantis sold 11,545 shares of the firm's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. The trade was a 68.85% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 30,111 shares of company stock valued at $15,364,055. 0.70% of the stock is owned by insiders.
Analyst Ratings Changes
Several brokerages recently issued reports on ISRG. Erste Group Bank lowered shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Barclays reduced their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. Robert W. Baird reduced their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, April 14th. Finally, Piper Sandler reduced their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. Five research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and a consensus target price of $596.05.
Read Our Latest Stock Report on ISRG
Intuitive Surgical Stock Down 0.8%
Shares of NASDAQ ISRG traded down $4.61 during trading on Friday, reaching $551.14. 2,091,011 shares of the company traded hands, compared to its average volume of 1,647,905. The firm has a 50 day simple moving average of $516.44 and a 200-day simple moving average of $538.53. The stock has a market capitalization of $197.54 billion, a PE ratio of 85.98, a P/E/G ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 52-week low of $396.48 and a 52-week high of $616.00.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same quarter last year, the firm posted $1.50 EPS. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.